Personal information

No personal information available

Activities

Collapse all

Works (8)

Comparative Study of Ensitrelvir and Symptomatic Therapy in Healthcare Workers with Mild COVID-19: A Single Center Retrospective Analysis in Chiba, Japan.

Journal of Infection and Chemotherapy
2025-02 | Journal article
DOI: 10.1016/j.jiac.2025.102668
Contributors: Jun Hirai; Yuki Hanai
Source: check_circle
Crossref

Evaluating Bezlotoxumab-Fidaxomicin Combination Therapy in Clostridioides Infection: A Single-Center Retrospective Study from Aichi Prefecture, Japan

Antibiotics
2025-02-24 | Journal article
DOI: 10.3390/antibiotics14030228
Contributors: Jun Hirai; Nobuaki Mori; Yuki Hanai; Nobuhiro Asai; Mao Hagihara; Hiroshige Mikamo
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Optimal Teicoplanin Trough Concentration With Therapeutic Drug Monitoring in Children: A Systematic Review and Meta-analysis

Therapeutic Drug Monitoring
2024-12 | Journal article
DOI: 10.1097/FTD.0000000000001230
Contributors: Yuki Hanai; Kazutaka Oda; Takashi Ueda; Kazuaki Matsumoto; Lisa Murakami; Shusuke Uekusa; Hayato Ohashi; Koji Nishimura; Yoshio Takesue; Kazuhiro Matsuo
Source: check_circle
Crossref

Risk factors for lenvatinib‐induced hypertension in patients with hepatocellular carcinoma: A retrospective study

British Journal of Clinical Pharmacology
2024-11-20 | Journal article
DOI: 10.1111/bcp.16337
Contributors: Shusuke Uekusa; Misaki Nakashin; Yuki Hanai; Maho Nemoto; Sachiko Yanagino; Yoshiki Arita; Takahiro Matsumoto; Noritaka Wakui; Hidenari Nagai; Koji Higai et al.
Source: check_circle
Crossref

Intraoperative redosing of antibiotics for prevention of surgical site infections: A systematic review and meta‐analysis

Annals of Gastroenterological Surgery
2024-10-18 | Journal article
DOI: 10.1002/ags3.12866
Contributors: Yuki Hanai; Jun Hirai; Masahiro Kobayashi; Kazuhiro Matsuo; Keita Kouzu; Hiroji Shinkawa; Seiichi Shinji; Motomu Kobayashi; Yuichi Kitagawa; Chizuru Yamashita et al.
Source: check_circle
Crossref

Predictive Value of Vancomycin AUC24/MIC Ratio for 30-day Mortality in Patients with Severe or Complicated Methicillin-Resistant Staphylococcus aureus Infections: A Multicenter Retrospective Study

Pharmaceutical Research
2024-07 | Journal article
DOI: 10.1007/s11095-024-03728-9
Contributors: Yuki Hanai; Hideki Hashi; Kazumi Hanawa; Aiju Endo; Taito Miyazaki; Tetsuo Yamaguchi; Sohei Harada; Takuya Yokoo; Shusuke Uekusa; Takaya Namiki et al.
Source: check_circle
Crossref

Risk factors for lenvatinib-induced hypertension in patients with hepatocellular carcinoma: a retrospective study

2024-05-16 | Preprint
DOI: 10.22541/au.171583925.52293360/v1
Contributors: Shusuke Uekusa; Misaki Nakashin; Yuki Hanai; Maho Nemoto; Sachiko Yanagino; Yoshiki Arita; Takahiro Matsumoto; Noritaka Wakui; Hidenari Nagai; Koji Higai et al.
Source: check_circle
Crossref

Favorable Effects of Voriconazole Trough Concentrations Exceeding 1 μg/mL on Treatment Success and All-Cause Mortality: A Systematic Review and Meta-Analysis

Journal of Fungi
2021-04 | Journal article | Author
DOI: 10.3390/jof7040306
Contributors: Yuki Hanai; YUKIHIRO HAMADA; TOSHIMI KIMURA; Kazuaki Matsumoto; Yoshiko Takahashi; Satoshi Fujii; Kenji Nishizawa; Yoshitsugu Miyazaki; Yoshio Takesue
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 23)‎

Peer review (27 reviews for 2 publications/grants)

Review activity for Journal of infection and chemotherapy. (22)
Review activity for Journal of pharmaceutical health care and sciences. (5)
How many people are using ORCID?